1 / 18

Introduction to laboratory medicine

Introduction to laboratory medicine. Lecture 4. Special chemistry. Definition Special Chemistry is a subsection of the Chemistry Laboratory of the Division of Clinical Pathology. This includes the tests which are not the part of the routine panel. Electrophoresis Urine chemistry

dessa
Télécharger la présentation

Introduction to laboratory medicine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Introduction to laboratory medicine Lecture 4

  2. Special chemistry Definition Special Chemistry is a subsection of the Chemistry Laboratory of the Division of Clinical Pathology. This includes the tests which are not the part of the routine panel. • Electrophoresis • Urine chemistry • Radioimmunoassay.

  3. Normal troponin levels 12 hours after chest pain has started mean a heart attack is unlikely

  4. Myloperoxidase (MPO) • Elevated in chronic conditions • CRP • Marker of atherosclerosis • Pregnancy associated plasma protein A (PAPPA) • elevated in atherosclerosis when atheroma is about to rupture • Oxidized LDL • A marker of atherosclerosis • Choline • Test of prognosis • Rises in chest discomfort even without rise in troponin level.

  5. Tumour markers A substance produced by tumour or by the host in response to tumour from normal tissues. May be present in blood, urine or tissues. Mostly they are antigens May be cytoplasmic proteins, enzymes and hormones.

  6. uses • Screening • Example: elevated prostate specific antigen suggests prostate cancer. • Monitoring of cancer survivors after treatment. Example: elevated AFP • Diagnosis of specific tumor types, particularly in certain brain tumors and other instances where biopsy is not feasible

  7. Ideal tumour marker Be specific to the tumor Level should change in response to tumor size An abnormal level should be obtained in the presence of micrometastases The level should not have large fluctuations that are independent of changes in tumor size Levels in healthy individuals are at much lower concentrations than those found in cancer patients Predict recurrences before they are clinically detectable Test should be cost effective

  8. SCREENING TESTS • Cancer must be common • The natural history of the cancer should be understood • Effective treatments must be available • The test must be acceptable to both patients and physicians • The test must be safe and relatively inexpensive

  9. GUIDELINES FOR ORDERING/INTERPRETING TUMOR MARKER TESTS • Never rely on the result of a single test • Order every test from the same laboratory • Consider half-life of the tumor marker when interpreting the result. • Consider how the Tumor Marker is removed or metabolized • Consider Hook Effect • Consider presence of HAMA antibodies

  10. Detection techniques

  11. Detection technique • Tumor markers can be detected by immunohistochemistry • Tissue selection • Fixation. • Tisue slicing by microtome. • Antigen antibody reaction. • Antibodies are labeled with some substance for detection enzyme, flurophore etc. • Amplification

  12. COMMON TUMOR MARKERS

  13. Benign conditions leading to high tumour marker level

  14. CEA • Described by Gold and Freedman in 1965 as a marker for Colorectal Cancer • Glycoprotein with a carbohydrate composition ranging from 50 - 85% of molecular mass • CEA levels 5 - 10 times upper limit of normal suggests colon cancer • CEA is not used to screen for colon cancer

  15. AFP • Tumour marker of hepatocellular carcinoma, as well as in the acute and chronic hepatitis. • Level is less than 10 ng/ml. • In person with no liver disease level upto 400ng/ml means liver cancer. But in patients with infections levels upto 4000ng/ml means liver cancer. • If tumour is removed fully with surgery then its level should go back to normal. • After surgery if level rises again then it means that tumour is back.

More Related